There was a significant difference regarding the percentages of IL-22-producing CD134+CD4+ T-cells in inactive SLE patients as compared HC (10.9 ± 9.2% vs. 19.0 ± 11.8%; p = 0.02). This evidence concerns the gene TNFRSF4 and systemic lupus erythematosus.